Literature DB >> 25723094

Graphene in neurosurgery: the beginning of a new era.

Maria Caffo1, Caffo Maria1, Lucia Merlo, Merlo Lucia, Daniele Marino, Marino Daniele, Gerardo Caruso, Caruso Gerardo.   

Abstract

Nanotechnology has revolutionized the approach to different fields of industry and medicine. Among the new nanomaterial used, one of the most promising appears to be graphene. Its versatility, due to a particular chemical configuration, confers to it enormous potential of application. Graphene has recently been tested also in biomedical research with excellent results. Neurosurgery can benefit of this material for therapeutic purposes such as targeting controlled drug/gene delivery in brain tumor treatment, as well as photothermal and photodynamic cancer therapy, improving biosensing and bioimaging, and lastly as biocompatible material for intracranial and/or spinal devices. However, it still remains an experimental material whose in vitro and in vivo toxicity is tested with controversial results for the human health. Noteworthy is the fact that it is not possible so far to know its long-term toxicity.

Entities:  

Keywords:  graphene; graphene oxide; neurosurgery; photothermal activity; toxicity

Mesh:

Substances:

Year:  2015        PMID: 25723094     DOI: 10.2217/nnm.14.195

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  2 in total

Review 1.  Toxicity of graphene-family nanoparticles: a general review of the origins and mechanisms.

Authors:  Lingling Ou; Bin Song; Huimin Liang; Jia Liu; Xiaoli Feng; Bin Deng; Ting Sun; Longquan Shao
Journal:  Part Fibre Toxicol       Date:  2016-10-31       Impact factor: 9.400

2.  Cellulose and Graphene Based Polyurethane Nanocomposites for FDM 3D Printing: Filament Properties and Printability.

Authors:  Izaskun Larraza; Julen Vadillo; Tamara Calvo-Correas; Alvaro Tejado; Sheila Olza; Cristina Peña-Rodríguez; Aitor Arbelaiz; Arantxa Eceiza
Journal:  Polymers (Basel)       Date:  2021-03-09       Impact factor: 4.329

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.